CIK 0001517022
- Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208756903
- Phone
- +1 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Open-market sale CCO sold 6,426 shares at $11.58 ($74,413)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, Chief Operating Officer sold 6,972 shares at $8.70 ($60,656)
- 4 Open-market sale SVP, Chief Legal Officer sold 7,050 shares at $8.70 ($61,335)
- 4 Open-market sale SVP, CFO & Treasurer sold 6,976 shares at $8.70 ($60,691)
- 4 Open-market sale SVP, Chief Development Officer sold 3,454 shares at $8.70 ($30,050)
- 4 Grant or award CEO and President acquired 237,400 shares (grant or award)
- 4 Grant or award SVP, Chief Medical Officer acquired 62,000 shares (grant or award)
- 4 Grant or award CCO acquired 55,000 shares (grant or award)
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Director bought 5,800 shares at $3.43 ($19,894)
- 4 Open-market buy Director bought 15,000 shares at $3.52 ($52,800)
- 4 Open-market buy SVP, Chief Medical Officer bought 27,000 shares at $3.58 ($96,660)
- 4 Open-market buy CEO and President bought 50,000 shares at $3.44 ($172,000)
- 4 Open-market buy Director bought 50,000 shares at $3.41 ($170,500)
- 4 Grant or award SVP, Chief Medical Officer acquired 10,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 9 of 19 · 378 filings